Lisa is currently the Director of the Process and Analytical Development Department at MilliporeSigma in St. Louis, where she oversees the development and transfer of custom projects into GMP manufacturing. The MilliporeSigma St. Louis site boasts over 20 years of experience in clinical and commercial manufacturing Antibody-Drug Conjugates (ADCs) and bioconjugates.
Lisa’s background includes 17 years at Monsanto as a synthetic organic chemist, working on both agricultural and pharmaceutical projects, followed by seven years at Pfizer, where she focused on establishing analytical control strategies for GMP success.
With over 30 years of experience in synthetic and analytical sciences, Lisa has contributed to numerous projects spanning from discovery to commercialization. However, none have been as exciting as the emergence of ADCs. She has presented MilliporeSigma’s ADC strategy at various external meetings, is a contributing author to the PDA TR56 Phase Appropriate Quality Systems for Therapeutic Proteins and serves as a session chair at World ADC conferences.